Chemoinformaics analysis of (6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)methyl 2-methylbutanoate
Molecular Weight | 236.355 | nRot | 4 |
Heavy Atom Molecular Weight | 212.163 | nRig | 9 |
Exact Molecular Weight | 236.178 | nRing | 3 |
Solubility: LogS | -5.137 | nHRing | 0 |
Solubility: LogP | 4.454 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 42.657 |
nHD | 0 | BPOL | 26.681 |
QED | 0.551 |
Synth | 4.357 |
Natural Product Likeliness | 1.719 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.028 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.352 |
MDCK | 0.0000215 |
BBB | 0.956 |
PPB | 0.696031 |
VDSS | 1.218 |
FU | 0.264726 |
CYP1A2-inh | 0.52 |
CYP1A2-sub | 0.213 |
CYP2c19-inh | 0.442 |
CYP2c19-sub | 0.797 |
CYP2c9-inh | 0.46 |
CYP2c9-sub | 0.407 |
CYP2d6-inh | 0.027 |
CYP2d6-sub | 0.388 |
CYP3a4-inh | 0.306 |
CYP3a4-sub | 0.32 |
CL | 12.811 |
T12 | 0.077 |
hERG | 0.001 |
Ames | 0.004 |
ROA | 0.032 |
SkinSen | 0.121 |
Carcinogencity | 0.708 |
EI | 0.912 |
Respiratory | 0.941 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.880577 |